Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Codeine Opioid Action Pathway
Homo sapiens
Drug Action Pathway
Codeine is an opioid agonist used for analgesia (pain-relief) and sedation similar to other opioid derivatives like morphine, methadone, fentanyl, hydrocodone and oxycodone. Codeine, like morphine is derived from the poppy plant, Papaver somniferum. Codeine is usually administered orally but can also be given subcutaneously or intramuscularly. When taken orally, it is absorbed through the GI tract into the bloodstream where it travels to the liver to be converted to morphine via P450 enzymes. The morphine that is produced from the conversion goes back into the blood where it will travel to the brain and cross the barrier to gain access to receptors on neurons. Opioids like codeine and morphine are agonists of all opioid receptors (mu, delta, and kappa), but codeine/morphine is more selective for the mu opioid receptor. Morphine will bind to mu opioid type receptors on pre-synaptic neurons. Morphine can also bind to post-synaptic neurons as well adding on to it's overall effects. On pre-synaptic mu opioid receptors, it will cause activation of them triggering inhibition of voltage gated N-type calcium channels adenylyl cyclase. Less calcium influx into the cell reduces neurotransmitter release into the synaptic cleft reducing neuronal transmission. Inhibiting adenylyl cyclase stops the conversion of ATP into cyclic AMP (cAMP) which has affects of analgesia. The mu opioid receptor activates the potassium inward rectifier channel (GIRK) moving more potassium out of the neuron hyperpolarizing the membrane potential. This makes action potentials much harder to achieve as the membrane potential is more negative. Through these effects, codeine reduces neuronal transmission of pain signals into the spinal chord and therefore less pain is perceived. Codeine has many sites of action where it can act on mu opioid receptors. It can act at the periphery to reduce neurogenic inflammation, the cingulate cortex altering the psychological response to pain, A delta and C pain fibres in the dorsal horn of the spinal chord and in the periaqueductal gray/rostral ventral medulla in the descending pain pathway that projects to the substantia gelatinosa. The inhibition of A delta and C pain fibres in the dorsal horn of the spinal chord is very important as it slows the signalling of pain into the spinal chord. Codeine can be used for treating coughing and mild to severe pain. Codeine due to euphoric, tranquil, sedative effects and addictive nature is/can be abused by patients or users who take the drug if not guided by a medical professional. Overdoses of codeine can lead to respiratory depression and eventual death.
References
Codeine Opioid Pathway References
Nassirpour R, Bahima L, Lalive AL, Luscher C, Lujan R, Slesinger PA: Morphine- and CaMKII-dependent enhancement of GIRK channel signaling in hippocampal neurons. J Neurosci. 2010 Oct 6;30(40):13419-30. doi: 10.1523/JNEUROSCI.2966-10.2010.
Pubmed: 20926668
Chan P, Lufty K. Molecular Changes in Opioid Addiction: The Role of Adenylyl Cyclase and cAMP/PKA System. Progress in Molecular Biology and Translational Science, Volume 137: 203-219, 2016.
Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M: DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. doi: 10.1093/nar/gkx1037.
Pubmed: 29126136
Takahama K, Shirasaki T: Central and peripheral mechanisms of narcotic antitussives: codeine-sensitive and -resistant coughs. Cough. 2007 Jul 9;3:8. doi: 10.1186/1745-9974-3-8.
Pubmed: 17620111
Raffa RB: A novel approach to the pharmacology of analgesics. Am J Med. 1996 Jul 31;101(1A):40S-46S. doi: 10.1016/s0002-9343(96)00137-4.
Pubmed: 8764759
Vree TB, van Dongen RT, Koopman-Kimenai PM: Codeine analgesia is due to codeine-6-glucuronide, not morphine. Int J Clin Pract. 2000 Jul-Aug;54(6):395-8.
Pubmed: 11092114
Srinivasan V, Wielbo D, Tebbett IR: Analgesic effects of codeine-6-glucuronide after intravenous administration. Eur J Pain. 1997;1(3):185-90. doi: 10.1016/s1090-3801(97)90103-8.
Pubmed: 15102399
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
Downloads
Settings